In the reports on vital capacity in the literature, instructions to the patients were not described in detail. In our experience variations in the results of serial determinations were traced in many ...

Up to 50% of patients with amyotrophic lateral sclerosis (ALS) have cognitive impairment, most commonly fronto-temporal dysfunction. Some patients seem to have reversible dysfunction in addition to ...

Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...

Evidence-based recommendations on nintedanib (Ofev) for treating idiopathic pulmonary fibrosis in adults when forced vital capacity is above 80% predicted. This technology appraisal is for treating ...